NCT04918537

Brief Summary

Shift workers are a growing population. It is well established that these workers face an increased risk of developing chronic diseases, but the underlying mechanisms remain debated. Various factors such as internal circadian desynchronization, unhealthy lifestyle behaviours, and lack of sleep interact in complex ways. Recently, it has been suggested that the gut microbiota (GM) may play an important role in this increased risk. The goal of this study is to describe the variations of the GM composition in shift workers across three different rotating weekly shifts (morning, afternoon, night) and to measure the impact of a 3- week walnuts supplementation intervention consisting in a controlled experimental study. Therefore, we propose a 6-weeks study including an observational and an experimental part. First, in the observational part, we will compare the gut microbiota of shift workers across three shifts (morning, afternoon and night). In the second part of the study, participants will add to their usual intakes a daily serving of nuts (30g). Again, we will compare the gut microbiota composition across the three types of shifts. During the study, participants will record their food intake, sleep and defecation time. We will also monitor their blood glucose levels continuously during the 4 first weeks of the study.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
18

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Apr 2021

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 12, 2021

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

June 2, 2021

Completed
7 days until next milestone

First Posted

Study publicly available on registry

June 9, 2021

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 31, 2022

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

September 30, 2022

Completed
Last Updated

May 16, 2022

Status Verified

May 1, 2022

Enrollment Period

12 months

First QC Date

June 2, 2021

Last Update Submit

May 12, 2022

Conditions

Keywords

Gut microbiota

Outcome Measures

Primary Outcomes (2)

  • Change in gut microbiota composition between the first and last day of each type of shift (observation phase)

    Change in relative abundance of bacteria phyla between the first and last day of each type of shift (AM, PM, N). Assessed by 16S rRNA sequencing approach.

    3 weeks (6 measurements over time)

  • Change in gut microbiota composition between the first and last day of each type of shift (observation vs intervention)

    Change in relative abundance of bacteria phyla between the first and last day of each type of shift (AM, PM, N). Assessed by 16S rRNA sequencing approach.

    6 weeks (12 measurements over time)

Secondary Outcomes (2)

  • Area under the blood glucose curve between each type of shift

    3 weeks

  • Area under the blood glucose curve in AM shift (observation vs intervention)

    week 1 vs 4

Other Outcomes (1)

  • Mean weekly frequency of defecation between each type of shift

    6 weeks

Study Arms (1)

Intervention walnuts

EXPERIMENTAL

During the 3 last weeks of the study, the participants will eat a 30g daily walnut serving

Dietary Supplement: Walnuts

Interventions

WalnutsDIETARY_SUPPLEMENT

30g of plain walnuts in addition to habitual food intakes

Intervention walnuts

Eligibility Criteria

Age18 Years - 65 Years
Sexmale
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Working 3x8 shifts (weekly rotations between AM, PM and N shifts) for at least 3 months prior to the study
  • No anticipated changes in shift work planning
  • No prebiotics or probiotics supplements.

You may not qualify if:

  • Antibiotic and/or immunomodulator use in the last 3 months or during the study
  • Change in medication during the last month or during study
  • Inflammatory bowel disease or important gut surgery
  • Nuts allergy
  • Major digestive tract surgery.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

School of Health Sciences Geneva

Geneva, Carouge, 1227, Switzerland

Location

MeSH Terms

Conditions

Dysbiosis

Condition Hierarchy (Ancestors)

Pathologic ProcessesPathological Conditions, Signs and Symptoms

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
PREVENTION
Intervention Model
SEQUENTIAL
Model Details: 3 weeks of observation 3 weeks of intervention
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Professor Assistant

Study Record Dates

First Submitted

June 2, 2021

First Posted

June 9, 2021

Study Start

April 12, 2021

Primary Completion

March 31, 2022

Study Completion

September 30, 2022

Last Updated

May 16, 2022

Record last verified: 2022-05

Data Sharing

IPD Sharing
Will share

De-identified individual participant data for all primary and secondary outcome measure will be made available.

Time Frame
Data will be available within 12 months of study completion
Access Criteria
At the end of the project the data will be deposited in the Yareta repository developed by the University of Geneva OR in an institutional repository. This choice will ensure that data is archived and shared in accordance with FAIR principles.

Locations